Le Lézard
Classified in: Health
Subject: MRR

Global Contract Development & Manufacturing Organization (CDMO) Industry Outlook to 2026, Featuring Profiles of Key Players Lonza Group, Catalent, Thermo Fisher, Jubilant Pharmova, and More


DUBLIN, Sept. 20, 2021 /PRNewswire/ -- The "Global Contract Development and Manufacturing Organization (CDMO) Market Report and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global contract development and manufacturing organization (CDMO) market attained a value of US$ 177.1 billion in 2020. Aided by the rising demand for pharmaceutical products, the market is projected to further grow at a CAGR of 8.4% between 2021 and 2026 to reach a value of US$ 302 billion by 2026.

Market Highlights

The expanding pharmaceutical sector will augment the demand for the contract development and manufacturing organization outsourcing market. To meet the high-volume demand for medications, pharma and biotech companies must have the manufacturing capacity to deliver the projected quantity while maintaining quality levels at a low cost.

Through the optimization of the supply chain and the enhancement of pharmaceutical companies' marketing capacities, the CDMO industry has been able to offer novel and effective pharmaceuticals to the market. This is increasing demand for the CDMO market.

The growing global population is accompanied with an increase in acute and chronic diseases. People's disposable income has increased as their understanding of healthcare has grown. This is fueling the market need for pharmaceutical items, resulting in the rapid rise of the CDMO industry. The increased investment of the industry in drug research and development and production is propelling the industry demand.

The North American market is one of the leading industries for contract development and manufacturing organizations (CDMO). This is due to the region's active CDMO key players, who are expanding partnerships and offering different service features.

Because of the large workforce with high capabilities and the reduced cost advantage in R&D and production, Asia-Pacific is projected to see substantial growth in CDMO. The CDMO industry in this region has also benefited from government regulations and an increased emphasis on off-patent medications.

Market Segmentation

Market Breakup by Service

Market Segmentation by CMO

Market Segmentation by CRO

Market Breakup by Region

Competitive Landscape

The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the key players in the industry. Some of the major players in the market explored in the report are:

Table of Contents

1 Preface
2 Report Coverage - Key Segmentation and Scope
3 Report Description
4 Key Assumptions
5 Executive Summary
6 Snapshot
7 Industry Opportunities and Challenges
8 Global Contract Development and Manufacturing Organization (CDMO) Market Analysis
9 Regional Analysis
10 Market Dynamics
11 Value Chain Analysis
12 Competitive Landscape
13 Industry Events and Developments

For more information about this report visit https://www.researchandmarkets.com/r/kwqw7k

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 13:30
The "Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global immunotherapy drugs market was valued at USD 169.47 billion in 2020 and is expected to reach USD 326.36...

at 13:20
Elemeno Health, the developer of a proprietary cloud-based solution for frontline healthcare teams, and LCMC Health, one of the fastest growing health systems in Louisiana, today announced a partnership to support neonatal ICU staff with just-in-time...

at 13:15
Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for sepsis testing,1 today announced the expansion of its senior leadership team with the...

at 13:09
EZC tackles the issue of problem gambling by telling real-life stories of three people currently in recovery in The Truth About Gambling, premiering Saturday, October 30th at 7 P.M. on local CBS Detroit. Their stories detail their road to addiction...

at 13:03
ImageFIRST Healthcare Laundry Specialists, a leading provider of laundry services for the healthcare industry, named the winner of its inaugural HeroesFIRST campaign ? Heidi Boyke of Waukesha, Wisconsin ? during International Infection Prevention...

at 13:00
Coforma has been awarded a one-year task order with the Department of Veterans Affairs (VA) to complete a COVID-19 Patient Manager Minimum Viable Product (MVP) tool and pilot rollout to key facilities. The task, valued at $5M, was awarded as a...



News published on 20 september 2021 at 17:30 and distributed by: